BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12842130)

  • 1. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.
    Duffy RA; Hedrick JA; Randolph G; Morgan CA; Cohen-Williams ME; Vassileva G; Lachowicz JE; Laverty M; Maguire M; Shan LS; Gustafson E; Varty GB
    Neuropharmacology; 2003 Aug; 45(2):242-50. PubMed ID: 12842130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
    Bristow LJ; Young L
    Eur J Pharmacol; 1994 Mar; 253(3):245-52. PubMed ID: 7515350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemokinin-1 and substance P stimulate production of inflammatory cytokines and chemokines in human colonic mucosa via both NK
    Dai L; Perera DS; Burcher E; Liu L
    Neuropeptides; 2020 Aug; 82():102061. PubMed ID: 32600668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, localization and receptor characterization of novel mammalian substance P-like peptides.
    Kurtz MM; Wang R; Clements MK; Cascieri MA; Austin CP; Cunningham BR; Chicchi GG; Liu Q
    Gene; 2002 Aug; 296(1-2):205-12. PubMed ID: 12383518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
    Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
    Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
    Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Braggio S; Carletti R; Gerrard PA; Griffante C; Marchioro C; Pozzan A; Melotto S; Poffe A; Piccoli L; Ratti E; Tranquillini E; Trower M; Spada S; Corsi M
    Bioorg Med Chem; 2013 Nov; 21(21):6264-73. PubMed ID: 24075145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms.
    Hunyady Á; Hajna Z; Gubányi T; Scheich B; Kemény Á; Gaszner B; Borbély É; Helyes Z
    Brain Res Bull; 2019 Apr; 147():165-173. PubMed ID: 30664920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
    Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
    J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.